NYSE:MD

Pediatrix Medical Group Reports First Quarter Results

Retrieved on: 
Tuesday, May 7, 2024
Health, Consumer, Hospitals, Women, Practice Management, Baby, Maternity, General Health, Debt-to-GDP ratio, Acquisition, Webcast, Depreciation, Public expenditure, Adjustment, Tax, GAAP, Physician, EPS

Investment and other income was $2.0 million for the first quarter of 2024, compared to $0.6 million for the first quarter of 2023.

Key Points: 
  • Investment and other income was $2.0 million for the first quarter of 2024, compared to $0.6 million for the first quarter of 2023.
  • Interest expense was $10.6 million for the first quarter of 2024 compared to $10.4 million for the first quarter of 2023.
  • For the first quarter of 2024, Pediatrix reported Adjusted EPS of $0.20, compared to $0.23 for the first quarter of 2023.
  • For the first quarter of 2024, Pediatrix used cash of $122.6 million to fund continuing operations, compared to a use of $100.6 million during the first quarter of 2023.

Pediatrix Medical Group 2024 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 7, 2024

Retrieved on: 
Monday, April 22, 2024
Health, Consumer, Hospitals, Practice Management, Baby, Maternity, General Health, MD, Webcast, Pediatrix Medical Group

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 7, 2024 at 9:00 a.m.

Key Points: 
  • Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 7, 2024 at 9:00 a.m.
  • ET to discuss results from operations for the quarter ended March 31, 2024.
  • A detailed press release will be issued the morning of May 7, 2024 before the securities markets open.
  • The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors .

Pediatrix Medical Group Reports Fourth Quarter Results

Retrieved on: 
Tuesday, February 20, 2024
Health, Consumer, Hospitals, Women, Baby, Maternity, General Health, Acquisition, Depreciation, Webcast, Coronavirus, Debt-to-GDP ratio, Adjustment, Economy, GAAP, Tax, Public expenditure, Economic security, EPS

For the fourth quarter of 2023, transformational and restructuring related expenses totaled $2.2 million, compared to $19.6 million for the fourth quarter of 2022.

Key Points: 
  • For the fourth quarter of 2023, transformational and restructuring related expenses totaled $2.2 million, compared to $19.6 million for the fourth quarter of 2022.
  • Depreciation and amortization expense of $9.1 million for the fourth quarter of 2023 was unchanged compared to the fourth quarter of 2022.
  • For the fourth quarter of 2023, Pediatrix reported Adjusted EPS from continuing operations of $0.32, compared to $0.47 for the fourth quarter of 2022.
  • For the fourth quarter of 2023, Pediatrix generated cash from continuing operations of $72.1 million, compared to $102.3 million for the fourth quarter of 2022.

Pediatrix® Medical Group to Host National Neonatology Meetings Feb. 19-24

Retrieved on: 
Tuesday, February 13, 2024
Health, Consumer, Practice Management, Other Health, Baby, Maternity, Pharmaceutical, Biotechnology, Accreditation, Woman, FAAP, NEO, Research, Accreditation Council, MD, Physician, Health Promotion International, Quality, Pediatrics, Clinical research, Continuing medical education, Life, Conference, ACCME, Infant, Pediatrix Medical Group, Patient, Teaching, MPH, DRH, Child, Education, Nursing

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada.

Key Points: 
  • Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada.
  • The meetings will host more than 600 combined attendees comprising neonatologists, neonatology fellows, pediatricians, advanced practice nurses and other allied health professionals, in addition to exhibitors and sponsors.
  • As a trusted provider of neonatology services for 45 years, Pediatrix cares for nearly a quarter of infants born in the U.S. that require intensive care.
  • , neonatologist and medical director at Pediatrix Neonatology of San Antonio, NEO continues its longstanding tradition of providing the latest information on key areas of neonatal management.

Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024

Retrieved on: 
Wednesday, February 7, 2024
Health, Consumer, Hospitals, Practice Management, Baby, Maternity, General Health, MD, Pediatrix Medical Group, Webcast, Cryptocurrency

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, February 20, 2024 at 9:00 a.m.

Key Points: 
  • Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, February 20, 2024 at 9:00 a.m.
  • ET to discuss results from operations for the quarter ended December 31, 2023.
  • A detailed press release will be issued the morning of February 20, 2024 before the securities markets open.
  • The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors .

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director

Retrieved on: 
Thursday, November 16, 2023
Premature, World Prematurity Day, NICU, Miller Children's Hospital, Canadian Neonatal Network, Health, Partnership, Communication, Neonatology, Hospital, Neonatal Network, Nursing, Pediatrix Medical Group

LONG BEACH, Calif., Nov. 16, 2023 /PRNewswire/ -- MemorialCare Miller Children's & Women's Hospital Long Beach, along with Pediatrix Medical Group, who has been a long-standing neonatology partner with MemorialCare, have come together to create the Miller Children's & Women's Neonatal Network. This new relationship enables coordinated delivery of provider services to the neonatal intensive care unit (NICU) network establishing a forum for improved communication, financial transparency, and shared program and provider planning. The Neonatal Network will have shared governance between Miller Children's & Women's and Pediatrix, with the neonatologists remaining employees of Pediatrix.

Key Points: 
  • The Neonatal Network will have shared governance between Miller Children's & Women's and Pediatrix, with the neonatologists remaining employees of Pediatrix.
  • Miller Children's & Women's features a level IV NICU, the highest designation in California, signifying it can care for the sickest and smallest babies.
  • To successfully execute this strategic initiative, Miller Children's & Women's has appointed Dr. Antoine Soliman as the Regional Medical Director of the Miller Children's & Women's Network.
  • "I'm deeply honored and humbled to accept the regional directorship of the Miller Children's & Women's Neonatal Network," says Dr. Soliman.

Pediatrix Medical Group Reports Third Quarter Results

Retrieved on: 
Thursday, November 2, 2023
General Health, Hospitals, Consumer, Health, Baby, Maternity, Adjustment, ET, Continuous operation, Tax, Public expenditure, EBITDA, GAAP, Pediatrix Medical Group, RCM, Webcast, EPS, Depreciation, Malpractice, Borrowing base, Debt-to-GDP ratio, Bookkeeping, Video game, Security (finance), Clothing, Cryptocurrency

Depreciation and amortization expense was $9.2 million for the third quarter of 2023, compared to $9.0 million for the third quarter of 2022.

Key Points: 
  • Depreciation and amortization expense was $9.2 million for the third quarter of 2023, compared to $9.0 million for the third quarter of 2022.
  • Investment and other income was $0.3 million for the third quarter of 2023, compared to $0.6 million for the third quarter of 2022.
  • For the third quarter of 2023, Pediatrix reported Adjusted EPS from continuing operations of $0.32, compared to $0.40 for the third quarter of 2022.
  • For the third quarter of 2023, Pediatrix generated cash from continuing operations of $81.1 million, compared to $88.4 million for the third quarter of 2022.

Pediatrix Medical Group 2023 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 2, 2023

Retrieved on: 
Friday, October 20, 2023
General Health, Health, Other Health, Pediatrix Medical Group, MD, NYSE, Webcast, Cryptocurrency

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m.

Key Points: 
  • Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m.
  • ET to discuss results from operations for the quarter ended September 30, 2023.
  • A detailed press release will be issued the morning of November 2, 2023 before the securities markets open.
  • The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors .

Pediatrix Medical Group Reports Second Quarter Results

Retrieved on: 
Thursday, August 3, 2023
Health, Consumer, Hospitals, Women, Other Health, Baby, Maternity, General Health, Borrowing base, Provisions of the Affordable Care Act, Pediatrix Medical Group, Continuous operation, Debt-to-GDP ratio, Tax, GAAP, Public expenditure, ET, EBITDA, Depreciation, Webcast, EPS, Adjustment, Pharmaceutical industry, Video game, Security (finance), Cryptocurrency, Bookkeeping

Depreciation and amortization expense was $8.9 million for the second quarter of 2023, compared to $8.8 million for the second quarter of 2022.

Key Points: 
  • Depreciation and amortization expense was $8.9 million for the second quarter of 2023, compared to $8.8 million for the second quarter of 2022.
  • Interest expense was $11.2 million for the second quarter of 2023, compared to $8.4 million for the second quarter of 2022.
  • For the second quarter of 2023, Pediatrix reported Adjusted EPS from continuing operations of $0.39, compared to $0.47 for the second quarter of 2022.
  • For the second quarter of 2023, Pediatrix generated cash from continuing operations of $92.6 million, compared to $81.6 million during the second quarter of 2022.

Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023

Retrieved on: 
Tuesday, July 18, 2023
Health, Hospitals, Practice Management, Other Health, Managed Care, General Health, Pediatrix Medical Group, Webcast, MD, NYSE, Cryptocurrency

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 3, 2023 at 9:00 a.m.

Key Points: 
  • Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 3, 2023 at 9:00 a.m.
  • ET to discuss results from operations for the quarter ended June 30, 2023.
  • A detailed press release will be issued the morning of August 3, 2023 before the securities markets open.
  • The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors .